토마티딘을 유효성분으로 포함하는 골질환의 예방 또는 치료용 약제학적 조성물
    3.
    发明公开
    토마티딘을 유효성분으로 포함하는 골질환의 예방 또는 치료용 약제학적 조성물 有权
    用于治疗和预防包含TOMATIDINE的骨质疏松症的药物组合物

    公开(公告)号:KR1020160071499A

    公开(公告)日:2016-06-22

    申请号:KR1020140178164

    申请日:2014-12-11

    CPC classification number: A61K31/585 A61K31/58 Y10S514/824

    Abstract: 본발명은토마티딘을포함하는골질환의예방또는치료용약제학적조성물을제공한다. 본발명의조성물은파골세포의형성을감소시켜골 흡수를억제하며이를통해다양한골질환의예방, 치료또는개선에매우효과적으로작용한다. 본발명은골다공증및 암세포의골전이로인하여발생된골질환에대하여예방및 치료효능을가지는토마티딘의의약및 식품으로서의기초적인자료를제공한다.

    Abstract translation: 在本发明中提供了一种用于预防或治疗包括tomatidine的骨病的药物组合物。 本发明的组合物通过减少破骨细胞的形成来抑制骨吸收,并且可以有效地用于预防,治疗或减轻各种骨疾病。 本发明提供了作为具有预防和治疗由癌细胞的骨转移产生的骨疾病和骨质疏松症的作用的托马替食的食品和药物的基本数据。

    후추 추출물을 함유하는 후각과민증 예방 또는 치료용 조성물
    4.
    发明公开
    후추 추출물을 함유하는 후각과민증 예방 또는 치료용 조성물 有权
    用于预防或治疗含有蛇麻素提取物的高血糖组合物

    公开(公告)号:KR1020160062791A

    公开(公告)日:2016-06-03

    申请号:KR1020140165277

    申请日:2014-11-25

    CPC classification number: A61K36/67

    Abstract: 본발명은후추추출물을유효성분으로후각과민증의예방및 치료용약학적조성물에관한것이다. 또한, 본발명은후추추출물을유효성분으로함유하는후각과민증의예방및 완화를위한건강기능식품에관한것이다. 본발명의조성물은후각신호전달을억제함으로써후각과민증을억제하는우수한효과가있다.

    Abstract translation: 本发明涉及一种用于预防和治疗含有胡椒提取物作为活性成分的高眼症的药物组合物。 本发明还涉及一种用于预防和缓解含有胡椒提取物作为活性成分的高眼症的功能性保健食品。 通过抑制嗅觉信号转导,本发明的组合物表现出优异的抑制高眼压的作用。

    미더덕 추출물을 함유하는 지방산 산화 촉진용 약학 조성물 또는 건강기능 식품
    7.
    发明公开
    미더덕 추출물을 함유하는 지방산 산화 촉진용 약학 조성물 또는 건강기능 식품 有权
    用于促进含有STYELA CLAVA提取物的脂肪酸氧化的药物组合物或功能食品

    公开(公告)号:KR1020130133563A

    公开(公告)日:2013-12-09

    申请号:KR1020120056917

    申请日:2012-05-29

    CPC classification number: A61K35/655 A23L33/10

    Abstract: The present invention relates to a composition for oxidation of fatty acid or a pharmaceutical composition or a functional health food for alleviating obesity, hyperlipidemia, insulin resistance syndrome, or metabolic syndrome, containing a Styela clava extract and, more specifically, to a Styela clava extract according to the present invention which has an effect of inhibiting fatty acid synthesis by suppressing the expression of SREBP-1c, fatty acid synthase (FAS), and ACC and promotes oxidation of fatty acid by downregulation of ACC and upregulation of CPT-1. [Reference numerals] (AA) Styela clava extract

    Abstract translation: 本发明涉及用于氧化脂肪酸的组合物或用于减轻含有施氏木酚提取物的肥胖,高脂血症,胰岛素抵抗综合征或代谢综合征的药物组合物或功能性保健食品,更具体地说,涉及施蒂氏 根据本发明,其通过抑制SREBP-1c,脂肪酸合酶(FAS)和ACC的表达来抑制脂肪酸合成的作用,并通过ACC的下调和CPT-1的上调促进脂肪酸的氧化。 (AA)Styela clava提取物

    루테올린을 유효성분으로 함유하는 후각과민증 예방 및 치료용 조성물
    8.
    发明公开
    루테올린을 유효성분으로 함유하는 후각과민증 예방 및 치료용 조성물 无效
    包含LUTEOLIN用于预防和治疗高血压的组合物

    公开(公告)号:KR1020130078309A

    公开(公告)日:2013-07-10

    申请号:KR1020110147176

    申请日:2011-12-30

    Abstract: PURPOSE: A pharmaceutical composition containing luteolin as an active ingredient for preventing and treating hyperosmia is provided to suppress recognition of disgusting smell from various olfactory stimulants by suppressing or reducing cyclic AMP (cAMP) generation, thereby effectively preventing and treating hyperosmia. CONSTITUTION: A pharmaceutical composition for preventing and treating hyperosmia contains luteolin as an active ingredient. Luteolin reduces cAMP concentration. The pharmaceutical composition is manufactured in a formulation selected from a group consisted of an oral formulation, an external use formulation, a suppository, a sterilized injection solution, and a spray. A health functional food for preventing and alleviating hyperosmia contains luteolin as an active ingredient. An aroma composition contains luteolin as an active ingredient.

    Abstract translation: 目的:提供含有木犀草素作为预防和治疗高血压的有效成分的药物组合物,通过抑制或减少环AMP(cAMP)的产生来抑制各种嗅觉兴奋剂对恶心呕吐的认识,从而有效预防和治疗高血糖。 构成:用于预防和治疗高血糖的药物组合物含有木犀草素作为活性成分。 木犀草素降低cAMP浓度。 药物组合物以选自口服制剂,外用制剂,栓剂,灭菌注射液和喷雾剂的组合物制成。 用于预防和缓解高血糖症的健康功能食品含有木犀草素作为活性成分。 芳香组合物含有木犀草素作为活性成分。

Patent Agency Ranking